News and Announcements

EU recommends AstraZeneca bladder cancer treatment for approval

By Benjamin Chiou

Date: Tuesday 27 May 2025

(Sharecast News) - EU regulators have recommended AstraZeneca's Imfinzi for approval in the treatment muscle-invasive bladder cancer (MIBC).
The recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency means that Imfinzi could be the first and only perioperative immunotherapy for adults with MIBC on...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page